trials

Optimizing Adaptive Design for Phase 2 Dose-finding Trials Incorporating Long-term Success and Financial Considerations: A Case Study for Neuropathic Pain

Biomarker Driven Population Enrichment for Adaptive Oncology Trials With Time to Event Endpoints

Optimizing Trial Design; Sequential, Adaptive and Enrichment Strategies

Biomarker Driven Population Enrichment for Adaptive Oncology Trials with Time to Event Endpoints

Repeated Confidence Intervals for Adaptive Group Sequential Trials